Ellevest, Inc. Bluebird Bio, Inc. Transaction History

Ellevest, Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 04, 2023	SELL	$3.14 - $8.22 $907 - $2,375	-289 Reduced 37.58%	480 $1,000
Q4 2022 Feb 03, 2023	SELL	$5.77 - $8.49 $86 - $127	-15 Reduced 1.91%	769 $5,000
Q3 2022 Nov 02, 2022	BUY	$3.75 - $7.39 $1,076 - $2,120	287 Added 57.75%	784 $5,000
Q2 2022 Jul 18, 2022	BUY	$2.94 - $5.23 $1,461 - $2,599	497 New	497 $2,000
Q3 2020 Oct 26, 2020	SELL	$34.44 - $43.75 $619 - $787	-18 Closed	0 $0
Q2 2020 Jul 06, 2020	SELL	$27.12 - $45.97 $2,549 - $4,321	-94 Reduced 83.93%	18 $1,000
Q1 2020 Apr 13, 2020	BUY	$26.16 - $63.5 $2,432 - $5,905	93 Added 489.47%	112 $5,000
Q4 2019 Feb 05, 2020	BUY	$46.96 - $61.67 $892 - $1,171	19 New	19 $2,000

112

61.5M

264K

428K

Ticker BLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,121,800
Market Cap $485M
Description
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...

Get notified when there are updates to the investment portfolio of Ellevest, Inc., based on Form 13F filings with the SEC.

Stay updated on Ellevest, Inc. with notifications on news.